导语保膀胱治疗是MIBC患者的重要治疗选择,尤其对于高龄、基础疾病多或强烈希望保留膀胱功能的患者,其核心目标是在保证肿瘤控制的前提下,最大限度提升生活质量。传统的三联疗法(经尿道切除术+放疗+化疗,TMT)已应用多年,但随着EV+P等高效围手术期方案、ctDNA/UTDNA等监测工具的出现,保膀胱治疗的模式正在发生深刻变革。无化疗保膀胱策略的探索、RETAIN等标志物指导研究的启示,为保膀胱治疗的精准化与个体化提供了新方向。本部分围绕保膀胱治疗的现状、创新策略与未来趋势,以一问一答形式展开讨论。... more
导语:新辅助治疗是MIBC综合治疗的核心环节,其目标是缩小肿瘤体积、降低分期、提高手术切除率与治愈率。随着EV-303、EV-304等研究的阳性结果公布,EV+P联合方案凭借高病理完全缓解率与生存优势,正在重塑MIBC新辅助治疗的标准。同时,分子标志物的应用、变异组织学患者的治疗选择,以及ctDNA/UTDNA在疗效监测中的价值,成为当前研究与临床实践的热点。本部分围绕新辅助治疗方案优选、分子标志物应用与疗效监测手段,以一问一答形式展开讨论。张瑞赟 教授:您目前治疗MIBC的一线首选新辅助治疗方... more
导语:辅助治疗是MIBC患者根治性手术后降低复发风险、改善生存预后的关键环节。随着EV系列研究等重磅成果的公布,EV+P(Enfortumab Vedotin+Pembrolizumab)围手术期模式展现出显著优势,而病理完全缓解(pCR)状态、肿瘤分期等因素,为辅助治疗方案的个体化选择提供了重要依据。本部分围绕新辅助治疗后不同病理反应患者的辅助治疗策略、争议焦点及决策依据,以一问一答形式展开深入探讨。张瑞赟 教授:新辅助化疗/EV方案治疗后达到病理完全缓解(ypCR)的MIBC患者,是否需要进... more
导语:液态活检技术的发展为MIBC辅助治疗的精准化提供了新工具,循环肿瘤DNA(ctDNA)作为反映微小残留病灶(MRD)的核心指标,在CheckMate 274、IMvigor011等研究中已展现出重要的预后与预测价值。ctDNA是否应常规用于指导辅助免疫治疗决策、最佳检测频率如何设定、检测结果(尤其是变异等位频率VAF)如何标准化解读,这些问题直接影响其临床转化与应用。本部分围绕ctDNA在辅助免疫治疗中的实践应用,以一问一答形式展开讨论。张瑞赟 教授:您在临床实践中是否常规使用ctDNA来... more
How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.
Apple Podcasts | #87 |










Listeners, social reach, demographics and more for this podcast.
| Gender Skew | Location | Interests | |||
|---|---|---|---|---|---|
| Professions | Age Range | Household Income | |||
| Social Media Reach | |||||
Rephonic provides a wide range of podcast stats for 肌肉浸润性膀胱癌(MIBC)管理. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to 肌肉浸润性膀胱癌(MIBC)管理 and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.
Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for 肌肉浸润性膀胱癌(MIBC)管理, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.
Rephonic provides comprehensive predictive audience data for 肌肉浸润性膀胱癌(MIBC)管理, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.
To see how many followers or subscribers 肌肉浸润性膀胱癌(MIBC)管理 has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.
肌肉浸润性膀胱癌(MIBC)管理 launched 8 days ago and published 4 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.
Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.
Rephonic pulls ratings and reviews for 肌肉浸润性膀胱癌(MIBC)管理 from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.
View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.
Rephonic provides full transcripts for episodes of 肌肉浸润性膀胱癌(MIBC)管理. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.